UDCA administration improved liver fibrosis, increased islet area, decreased glucose levels, inhibited genes in BA synthesis, enhanced TGR5 gene expression in the intestine, and further improved islet function. This evidence concerns the gene GPBAR1 and Hepatic fibrosis.